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Objectives-To determine the frequency and mode of inheritance of familial dilated cardiomyopathy in the United Kingdom. Background-Two recent prospective studies have suggested that familial forms of dilated cardiomyopathy are common but have been limited by selective screening methods, inadequate diagnostic criteria, and low rates of ascertainment. Methods-Prospective screening study of 236 relatives from 40 families of patients with dilated cardiomyopathy. Screening consisted of clinical examination, 12 lead electrocardiogram, and two-dimensional Doppler echocardiography. Relatives with systemic hypertension and other cardiac diseases were excluded from the study. All echocardiograms were performed by an experienced echocardiographer who was blinded to clinical information. Relatives were classified as having dilated cardiomyopathy, left ventricular enlargement (method of Henry) , depressed fractional shortening, or as being normal. Relatives with abnormal investigations underwent further evaluation as appropriate. Results-Twenty five cases of dilated cardiomyopathy were identified and came from 10 (25%) of the 40 families screened. Pedigree analysis was most consistent with autosomal dominant inheritance and variable penetrance (65-95%). Of the remaining apparently healthy relatives, 37 (18%) were found to have left ventricular enlargement and nine (4%) depressed fractional shortening; these values were significantly higher than those observed in 239 healthy controls (24 (10%), P = 0'02 and one (0.4%), P = 0-01, respectively). 
Conclusions-Patients

Discussion
In this study we prospectively screened 236 relatives from 40 families of patients with dilated cardiomyopathy applying strict diagnostic criteria9 10 and achieving high levels of ascertainment. We have confirmed the recent report from the Mayo Clinic* that dilated cardiomyopathy is commonly familial and most consistent with autosomal dominant inheritance with incomplete penetrance. In addition, we have shown that a high proportion of apparently healthy relatives have left ventricular enlargement (18%) or depressed fractional shortening (4%). The relevance of this finding in relation to the presence of early dilated cardiomyopathy remains to be established. In the present study screening was offered to families able to provide the necessary family information who were willing or able to undergo screening at our centre; however, families with small living pedigrees, missing important family members, or uncertain parentage were not offered screening. We recognise the potential for selection bias introduced by such an approach but these practical difficulties affect all family screening studies, particularly in cases involving rare conditions such as dilated cardiomyopathy, performed from a single centre. Despite this limitation it is important to emphasise that we like Michels et a1 but unlike others7 offered screening to families irrespective of the presence or absence of suspected familial disease. This is important given the observation that affected relatives are often asymptomatic and can be identified only through prospective screening; this is likely to explain the lower estimate of familial prevalence (7%) from Italy.7 In the present study index patients who participated in screening were similar to those who did not and supports our belief that the families screened in the present study are mainly representative of families of patients with dilated cardiomyopathy. It is important, however, as with all prospective studies, to recognise the potential for referral bias. In our centre, as in all tertiary centres, patients with suspected familial dilated cardiomyopathy are more likely to be referred for assessment than patients considered at low risk of familial disease leading to an over-estimation of familial prevalence.
Dilated cardiomyopathy is multicausal and it is often not possible to accurately define the aetiology. Identification of individuals with familial dilated cardiomyopathy, which is probably genetic in aetiology, enabled us to determine whether "genetic" disease differed from that more likely to have an environment aetiology. Although patients with and without affected relatives were similar in most respects, those with familial disease had a longer symptomatic illness, better exercise capacity, and less marked left ventricular dilatation or dysfunction. Whether these observations reflect genuine differences in the clinical presentation and natural history between genetic and non-genetic dilated cardiomyopathy remains to be confirmed. The In this study we have shown that patients with dilated cardiomyopathy commonly have a close family member similarly affected. Analysis of these families suggests that familial dilated cardiomyopathy is likely to be caused by the transmission of a rare autosomal dominant gene within the family. Although the molecular basis of familial dilated cardiomyopathy is currently unknown, linkage analysis promises to identify the gene(s) responsible and thereby improve our ability to identify not only affected individuals but also those with preclinical disease.
